Blastocyst
9
0
0
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 9 trials
100.0%
+13.5% vs benchmark
11%
1 trials in Phase 3/4
0%
0 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (9)
The Influence of Sperm Morphology and Functional Indices on Blastocyst Development in Assisted Reproduction
Protocol with Progestin-primed Ovarian Stimulation (PPOS) from the Beginning of Stimulation Versus Protocol with GnRH Antagonists for Ovarian Stimulation in Patients Undergoing DUOSTIM with Embryo Accumulation for PGT-A.
Effect of Sars-cov-2 on Donor Oocyte Quality and Quantity, a Multicenter Retrospective Study.
Sperm DNA Fragmentation Effects on Blastocyst Morphology Grading, Pregnancy Rate and Implantation Rate
Adding Antioxidants Into Human Sequential Culture Media System
Comparisons of Human Embryonic Development Using Single Medium With and Without the Addition of Antioxidants
Influence of Culture Media on Clinical Outcomes in Poor Responders or Severe Male Infertility
Cryosurvival of Embryos From Dysmorphic Oocytes
The Human Blastocyst Secretome and Implantome